Navalign, LLC Zoetis Inc. Transaction History
Navalign, LLC
- $336 Million
- Q4 2024
A detailed history of Navalign, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Navalign, LLC holds 5,638 shares of ZTS stock, worth $927,056. This represents 0.27% of its overall portfolio holdings.
Number of Shares
5,638
Previous 5,426
3.91%
Holding current value
$927,056
Previous $1.06 Million
13.4%
% of portfolio
0.27%
Previous 0.31%
Shares
15 transactions
Others Institutions Holding ZTS
# of Institutions
2,062Shares Held
420MCall Options Held
1.22MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.4MShares$6.8 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.06 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.26 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.63 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.95 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $77B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...